Lilly signs gene editing deal worth up to $555M with Durham’s Precision BioSciences
Date Published:
DURHAM – Drug giant Eli Lilly, which is building a pharmaceutical production plant in the Triangle, now has another 555…
Life Sciences
‘Gigafactory’ campus for vaccine production, hundreds of jobs coming to Triangle
Date Published:
DURHAM – A 1 million-square-foot campus, including a massive “gigafactory” to manufacture vaccine and therapeutic prefilled plastic injectors in the…
Syringe company plans $800 million, 650-job plant in RTP
Date Published:
Stamford, Conn.-based ApiJect Ltd. plans a 1 million-square-foot plant in Research Triangle Park to make billions of syringes to be…
Gene editing firm Locus Biosciences adds another $7M to its 2020 cash haul
Date Published:
MORRISVILLE – Gene editing startup Locus Biosciences has landed another $7 million in new cash, adding to a year that…
Duke researchers help develop biomaterial that improves skin healing
Date Published:
DURHAM – Researchers at Duke University and the University of California, Los Angeles, have developed a biomaterial that significantly reduces…
Pfizer: Coronavirus vaccine proves 90% effective in early data from trial
Date Published:
Drugmaker Pfizer said Monday an early look at data from its coronavirus vaccine shows it is more than 90% effective…
Alzheimer’s drug from Biogen fails to win support of FDA advisory committee
Date Published:
An advisory committee to the US Food and Drug Administration largely concluded in a meeting on Friday that there is…
Duke-led team finds genetic marker that could boost fight against infant brain damage
Date Published:
DURHAM – A Duke Health-led research team has identified a key marker that will help speed effective vaccine designs for…
Durham medtech startup 410 Medical receives FDA clearance for fluid administration device
Date Published:
DURHAM – Durham startup 410 Medical has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for its LifeFlow PLUS…